Fidelity Adv Biotechn Z FIJYX
MF · Open-End Fund · CUSIP 315918243
1
institutional holders
+0 vs Q1 2026
9.3k
shares reported held*
$467.7kreported value*
0 new
1 added
0 reduced
0 sold out
net bought ≈ $100.2k (+2.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $50.33.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2023 | 1 |
| Q1 2024 | 1 |
| Q2 2024 | 1 |
| Q3 2024 | 1 |
| Q4 2024 | 1 |
| Q1 2025 | 1 |
| Q2 2025 | 0 |
| Q3 2025 | 1 |
| Q4 2025 | 1 |
| Q1 2026 | 1 |
| Q2 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 0 | 0 |
| Q4 2024 | 1 | 0 |
| Q1 2025 | 0 | 0 |
| Q2 2025 | 0 | 1 |
| Q3 2025 | 1 | 0 |
| Q4 2025 | 1 | 0 |
| Q1 2026 | 0 | 0 |
| Q2 2026 | 1 | 0 |
Biggest buyers
| Sequent Asset Management, LLC | Added | +2.0k |
Biggest sellers
| None |
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Sequent Asset Management, LLC 0.20% of their portfolio | 9.3k $467.7k | Added +2.0k |